Syringaresinol-4-O-β-d-glucoside alters lipid and glucose metabolism in HepG2 cells and C2C12 myotubes

Syringaresinol-4-O-β-d-glucoside (SSG), a furofuran-type lignan, was found to modulate lipid and glucose metabolism through an activity screen of lipid accumulation and glucose consumption, and was therefore considered as a promising candidate for the prevention and treatment of metabolic disorder,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuai, Wu, Chongming, Li, Xin, Zhou, Yue, Zhang, Quanyang, Ma, Fuchao, Wei, Jianhe, Zhang, Xiaopo, Guo, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518665/
https://www.ncbi.nlm.nih.gov/pubmed/28752030
http://dx.doi.org/10.1016/j.apsb.2017.04.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518665/
https://www.ncbi.nlm.nih.gov/pubmed/28752030
http://dx.doi.org/10.1016/j.apsb.2017.04.008

Ejemplares similares